SCHEMBL821152

SCHEMBL821152

CCc1ccc2c(c1)c(C)cn2C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 3/20 0.40
LMNA P02545 2/20 0.40
PGR P06401 1/20 0.40
RORA P35398 1/20 0.40
RORC P51449 1/20 0.40
RORB Q92753 1/20 0.40
ALDH1A1 P00352 1/20 0.40
THRB P10828 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
HTT P42858 1/20 0.40
CHRNA7 P36544 1/20 0.40
CACNA1H O95180 7/20 0.38
GAA P10253 2/20 0.38
PTPN5 P54829 1/20 0.37
HTR1D P28221 1/20 0.36
PSEN1 P49768 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18509026 0.85 SCN9A (0.39) MEN1KMT2AMAPTLMNAPGR
SCHEMBL13886016 0.84 CHRNA7 (0.42) MAPTPGRALDH1A1HPGDCHRNA7
SCHEMBL19693056 0.84 PRKCB (0.45) CHRNA7CACNA1HHTR1D
SCHEMBL23917680 0.81 MAPT (0.49) MEN1KMT2AMAPTLMNAPGR
SCHEMBL20562376 0.81 HTR1D (0.50) MAPTLMNAALDH1A1CHRNA7CACNA1H
SCHEMBL19506275 0.81 HTR1D (0.40) MEN1KMT2AMAPTLMNAPGR
SCHEMBL12109755 0.80 MAPT (0.40) MEN1KMT2AMAPTLMNAPGR
SCHEMBL17316760 0.78 KDM4E (0.64) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL5985874 0.76 KDM4E (0.41) MEN1KMT2AMAPTPGRRORA
SCHEMBL11400946 0.76 SCN9A (0.36) MEN1KMT2AMAPTLMNAPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110288116-A1 IAP INHIBITORS TETRALOGIC PHARMACEUITCAL CORPORATION (US) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288116-A1 IAP INHIBITORS XIAP, BIRC5, BIRC7 MEN1 1940/4885KMT2A 4487/4885MAPT 1439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.